Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Farouk Al-Chami"'
Publikováno v:
American Heart Journal Plus, Vol 34, Iss , Pp 100320- (2023)
Background: Early data on use of catheter-directed therapies (CDT) for treatment of Intermediate or High-Risk pulmonary embolism (PE) show improvement in pulmonary artery systolic pressures (PAsP) and RV/LV ratios. Occasionally a paradoxical rise in
Externí odkaz:
https://doaj.org/article/551fa2e1541c4b69a9df38fa2f0bdf28
Autor:
Jean El Cheikh, Samantha El Warrak, Nohra Ghaoui, Farouk Al Chami, Maya Shahbaz, Sarah Chehayeb, Nagi Saghir, Ali Bazarbachi, Ali Taher
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21st of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU
Externí odkaz:
https://doaj.org/article/d9f9e0e73c3345e785904ee84c964412
Autor:
Jean El Cheikh, Iman Abou Dalle, Jeries Kort, Farouk Al Chami, Maya Charafeddine, Haidar El Darsa, Rola El Sayed, Ali Ibrahim, Ali Bazarbachi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:711-719
Background Intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone (R-ACVBP) improves outcomes in younger adults with diffuse large B-cell lymphomas (DLBCL) compared with R-CHOP. Due to vinde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb221ada056bc9156e6edcaf2f67673
https://doi.org/10.1016/j.clml.2021.05.011
https://doi.org/10.1016/j.clml.2021.05.011
Autor:
Hani Tamim, Aseel Sarieddine, Kinda Sweidan, Farouk Al Chami, Rola Cheaito, Ali Bazarbachi, Imad El Majzoub, Jean El Cheikh, Mohamad Ali Cheaito
Publikováno v:
The American Journal of Emergency Medicine. 46:295-302
Bone marrow transplantation is a breakthrough in the world of hematology and oncology. In our region, there is scarce literature studying emergency department visits among BMT patients, as well as their predictors of mortality.This study aimed to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bbc6e59cc0bc31fa7f1ebab408c310
https://doi.org/10.1016/j.ajem.2020.07.085
https://doi.org/10.1016/j.ajem.2020.07.085
Autor:
Thomas Pagliardini, Raynier Devillier, Nohra Ghaoui, Remy Dulery, Radwan Massoud, Farouk Al Chami, Florent Malard, Didier Blaise, Nour Moukalled, Jean El-Cheikh, Razan Mohty, Fabrizio Marino, Mohamad Mohty, Luca Castagna, Ali Bazarbachi, Abdul Hamid Bazarbachi
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, 2020, 20 (9), pp.617-623. ⟨10.1016/j.clml.2020.04.003⟩
Clinical Lymphoma, Myeloma & Leukemia, 2020, 20 (9), pp.617-623. ⟨10.1016/j.clml.2020.04.003⟩
Background Graft-versus-host disease (GVHD) is a major cause of mortality after allogeneic stem-cell transplantation. Posttransplantation cyclophosphamide (PT/CY) has become standard prophylaxis of GVHD in T-replete haploidentical transplantation. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34703a584d1d166a50591a5c69dff379
https://doi.org/10.1016/j.clml.2020.04.003
https://doi.org/10.1016/j.clml.2020.04.003
Autor:
JOSEPH V MORAN, FAROUK AL CHAMI
Publikováno v:
Chest. 162:A2227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17de0388b209b4460dfb31c471445522
https://doi.org/10.1016/j.chest.2022.08.1842
https://doi.org/10.1016/j.chest.2022.08.1842
Publikováno v:
Chest. 162:A533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb10ee683f8022768e9e847c3c83ba2e
https://doi.org/10.1016/j.chest.2022.08.412
https://doi.org/10.1016/j.chest.2022.08.412
Autor:
Haidar El Darsa, Farouk Al Chami, Jeries Kort, Rola El Sayed, Charafeddine Maya, Jean El-Cheikh, Ali Bazarbachi, Iman Abou Dalle
Publikováno v:
Blood. 136:49-50
Background: Intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone (R-ACVBP) has been shown to improve outcomes in younger adults with high-grade B-cell lymphomas (hg-BCL) when compared to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64416d609c47cf61fadadf280ac47b34
https://doi.org/10.1182/blood-2020-142544
https://doi.org/10.1182/blood-2020-142544
Autor:
Angelo Michele Carella, Emanuele Angelucci, Farouk Al-Chami, Francesca Bonifazi, Jean El-Cheikh, Anna Paola Iori, Arnon Nagler, Myriam Labopin, Luca Castagna, Benedetto Bruno, Mohamad Mohty, Ali Bazarbachi, Stella Santarone, Giorgio La Nasa, Bipin N. Savani
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(5)
Background Allogeneic stem cell transplantation is a potentially curative therapy for patients with acute myeloid leukemia (AML) after achieving complete remission (CR). The aim of this study is to evaluate the optimal dose of thiotepa, administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675e7dd30303bd281535023691cc16a4
https://pubmed.ncbi.nlm.nih.gov/32081702
https://pubmed.ncbi.nlm.nih.gov/32081702
Autor:
Iman Abou Dalle, Firas Kreidieh, Ali Bazarbachi, Razan Mohty, Rami Mahfouz, Elizabeth M. Kfoury Baz, Farouk Al-Chami, Jean El Cheikh, Ali Ibrahim
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S218
Context Outcomes of haplo-identical hematopoietic stem cell transplantation (haploSCT) have recently improved due to better control of allo-reactive reactions related to the major HLA mismatch between the recipient and the donor. Presence of pretrans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02d972a9ab8e6cb02dff717272f6155d
https://doi.org/10.1016/s2152-2650(20)30785-0
https://doi.org/10.1016/s2152-2650(20)30785-0